Skip to main content
Pills

The Solution to Soaring Drug Prices? A Public Option for Pills

Vishal Khetpal writes how with public opinion of Big Pharma near an all-time low, it’s time for the government to enter the generic drug business, citing The Democracy Collaborative’s report “Medicine for All.”

With prescription drug costs continuing to grow, lawmakers on both sides of the aisle have proposed pegging drug prices to an international index and granting states permission to import drugs from Canada. Among the public, both Democrats and Republicans have shown support for allowing Medicare to negotiate drug prices with pharmaceutical companies. But the moment might be ripe for an even bolder idea: letting the federal government get into the business of generic drug manufacturing, essentially creating a public option for generic drugs.

The idea isn’t new. Already, a group of large, private health care providers has come together to develop a not-for-profit generic drug manufacturer, called Civica Rx. And government-run drug manufacturing was proposed in a 2018 bill co-sponsored by Senator Elizabeth Warren, who has also included it in her campaign platform on health care. The nonprofit Democracy Collaborative recently commissioned a comprehensive report examining the idea, and just last month, California Governor Gavin Newsom announced a plan for the state to create its own generic drug label.

Read the entire article on Undark, or Salon.

Publication date: 2020-03-02
Parent publication: Salon
Publication URL: https://www.salon.com/2020/03/01/the-solution-to-soaring-drug-prices-a-public-option-for-pills_partner/

More related work

March 19, 2020
Default Image

Protect the vulnerable, advance the democratic economy: Our statement on the COVID-19 crisis

We are in a period of breakdown, in which all that is wrong with the current system is now being laid bare. Rather than rebuild what we now clearly see should never have been, we must lead the construction out of this crisis of something new.

read more
March 18, 2020
Default Image

HAN Public Comments on Fair Housing Act Proposed Changes

The Healthcare Anchor Network submitted public comments to the Department of Housing and Urban Development (HUD), expressing our opposition to HUD’s proposed changes to the 2015 Affirmatively Furthering Fair Housing rule.

read more
March 17, 2020
An array of prescription medications on shelves

Online press briefing: Vaccines—The COVID-19 Case for Public Pharmaceutical Research and Development

Leading experts believe that it is the government’s responsibility to ensure widespread access to safe and effective vaccines that are developed with taxpayer money. In this virtual press briefing, hear why the U.S. government should develop and manufacture vaccines and other essential medicines so that we get the medicines we need, when we need them and at prices we can afford.

read more